Patent · US Active

Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof

US10716760B2 · kind B2 · utility

0Cited by

42References

18Claims

0Family size

Assignee

ARBOR PHARMACEUTICALS, LLC · US

Inventors

Sami Karaborni · Cupertino, US
Sarina Grace Harris Ma · Santa Clara, US
Chen Mao · Shanghai, CN
Ching Wah Chong · Fremont, US
Peter Robert Prinz Freed · Linglestown, US
Mesut Ciper · Oelde, DE
Stefanie Krenzlin · Munster, DE
David Juergen Wustrow · Ann Arbor, US
Peter A. Virsik · Portola Valley, US

Key dates

Filing date	Jan 7, 2016
Grant date	Jul 21, 2020
Priority date	—
Expiry date	Jan 7, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Improved oral dosage forms of methyl hydrogen fumarate and prodrugs thereof are disclosed. Methods of treating diseases such as multiple sclerosis and psoriasis using such dosage forms are also disclose.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.